These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32869917)

  • 21. Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis.
    Wang J; Tao Y; Zhao F; Liu T; Shen X; Zhou L
    Ren Fail; 2023 Dec; 45(1):2121929. PubMed ID: 36695327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stratification of diabetic kidney diseases
    Huang Q; Fei X; Zhong Z; Zhou J; Gong J; Chen Y; Li Y; Wu X
    Front Endocrinol (Lausanne); 2022; 13():995362. PubMed ID: 36465646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum MicroRNA Differences Between Fracture in Postmenopausal Women with and without Diabetes.
    Ren C; Li M; Sun L; Li Z; Lu Y; Wang Q; Ma T; Xue HZ; Zhang K
    Orthop Surg; 2021 Feb; 13(1):285-295. PubMed ID: 33283469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and functional prediction of the microRNAs differentially expressed in a mouse model of concanavalin A-induced autoimmune hepatitis.
    Liu Y; Chen H; Hao J; Li Z; Hou T; Hao H
    Int J Med Sci; 2020; 17(15):2312-2327. PubMed ID: 32922197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology.
    Li X; Zhang X; Wang S; Li Y; Meng C; Wang J; Chang B; Yang J
    Front Endocrinol (Lausanne); 2024; 15():1443573. PubMed ID: 39229378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease.
    Ren H; Shao Y; Ma X; An L; Liu Y; Wang Q
    Arch Physiol Biochem; 2024 Jun; 130(3):285-299. PubMed ID: 35147479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
    Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
    J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
    Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
    Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
    Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
    Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-30e-5p and MiR-15a-5p Expressions in Plasma and Urine of Type 1 Diabetic Patients With Diabetic Kidney Disease.
    Dieter C; Assmann TS; Costa AR; Canani LH; de Souza BM; Bauer AC; Crispim D
    Front Genet; 2019; 10():563. PubMed ID: 31249597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AKT2 identified as a potential target of mir-29a-3p via microRNA profiling of patients with high proliferation lacrimal gland adenoid cystic carcinoma.
    Zhao J; Liu X; Lin J; Jiang M; Xu F; Zhang C; Tang Q; Zhu L; Dong L; Lin T
    Exp Eye Res; 2022 Jun; 219():109067. PubMed ID: 35398208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease.
    Zhou LT; Lv LL; Qiu S; Yin Q; Li ZL; Tang TT; Ni LH; Feng Y; Wang B; Ma KL; Liu BC
    J Transl Med; 2019 Feb; 17(1):59. PubMed ID: 30819181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes.
    Altman J; Bai S; Purohit S; White J; Steed D; Liu S; Hopkins D; She JX; Sharma A; Zhi W
    J Proteomics; 2024 May; 300():105167. PubMed ID: 38574989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
    Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
    Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
    Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.